These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. How skeptical should we be about industry-sponsored studies? Chadwick D; Privitera M Neurology; 2006 Aug; 67(3):378-9. PubMed ID: 16894094 [No Abstract] [Full Text] [Related]
43. [Debate on clinical research without distortion of proportions]. Verland K Ugeskr Laeger; 2005 Apr; 167(14):1489. PubMed ID: 15887739 [No Abstract] [Full Text] [Related]
44. Industry sponsored research. Klotz LH Can J Urol; 2004 Aug; 11(4):2312-3. PubMed ID: 15380051 [No Abstract] [Full Text] [Related]
45. Ethical issues in the relationships involving medicine and industry. Thomas PS; Tan KS; Yates DH Intern Med J; 2005 Dec; 35(12):732. PubMed ID: 16313554 [No Abstract] [Full Text] [Related]
46. The role of pharmaceutical companies in sponsored research. Novack GD Ophthalmology; 2007 Jun; 114(6):1037-8. PubMed ID: 17544773 [No Abstract] [Full Text] [Related]
47. [Constraints on publication rights in industry-initiated clinical trials--secondary publication]. Gøtzsche PC; Hróbjartsson A; Johansen HK; Haahr MT; Altman DG; Chan AW Ugeskr Laeger; 2006 Jun; 168(25):2467-9. PubMed ID: 16824372 [TBL] [Abstract][Full Text] [Related]
48. Extent and impact of industry sponsorship conflicts of interest in dermatology research. Perlis CS; Harwood M; Perlis RH J Am Acad Dermatol; 2005 Jun; 52(6):967-71. PubMed ID: 15928613 [TBL] [Abstract][Full Text] [Related]
49. Conflict of interest in clinical research: direct payment to the investigators for finding human subjects and health information. Puttagunta PS; Caulfield TA; Griener G Health Law Rev; 2002; 10(2):30-2. PubMed ID: 15739309 [TBL] [Abstract][Full Text] [Related]
50. Worrisome ailment in medicine: misleading journal articles; editors demand more data to ensure full disclosure of drug risks, trial gaps; Sarbanes-Oxley for professors. Mathews AW Wall St J (East Ed); 2005 May; ():A1, A9. PubMed ID: 15966125 [No Abstract] [Full Text] [Related]
52. Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs? Yes. Goldacre B BMJ; 2009 Nov; 339():b4949. PubMed ID: 19946143 [No Abstract] [Full Text] [Related]
53. [The difficult relationship of industry and science. Money versus research]. Wessling A Pflege Z; 2011 Aug; 64(8):454-5. PubMed ID: 21882617 [No Abstract] [Full Text] [Related]
54. Task force ready on financial conflict of interest in research. Maloney DM Hum Res Rep; 2001 May; 16(5):4. PubMed ID: 11833561 [No Abstract] [Full Text] [Related]
55. [Clinical intervention research: two editorials and one discussion]. Jensen GB; Ersbøll J Ugeskr Laeger; 2005 May; 167(21):2307-8; author reply 2308-10. PubMed ID: 15962866 [No Abstract] [Full Text] [Related]
56. Policy of the American Society of Gene Therapy on financial conflict ofinterest in clinical research. Woo SL Mol Ther; 2000 May; 1(5 Pt 1):383-4. PubMed ID: 10979736 [No Abstract] [Full Text] [Related]
57. Sponsorship, authorship and accountability. Holmer AF N Z Med J; 2001 Dec; 114(1145):558; author reply 559. PubMed ID: 11833959 [No Abstract] [Full Text] [Related]
58. Factor VIIa for ICH: behind the scenes of an academic-industry collaborative trial. Mayer SA; Davis S; Steiner T; Diringer MN; Broderick J Int J Stroke; 2007 Aug; 2(3):164-8. PubMed ID: 18705937 [No Abstract] [Full Text] [Related]
59. Challenges in science and academic-industry interactions. Eisman JA; Lorenzo JA J Bone Miner Res; 2007 Nov; 22(11):1654-5. PubMed ID: 17931099 [No Abstract] [Full Text] [Related]
60. Getting it right: industry sponsorship and medical research. Baird P CMAJ; 2003 May; 168(10):1267-9. PubMed ID: 12743071 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]